ERIC SOUTHARD: Open Payments
NPI 1306825153 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 13 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $20 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $86 |
| PFIZER INC. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Novo Nordisk Inc | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Lilly USA, LLC | 1 | $17 |
Products named: OTEZLA, ELIQUIS, TRELEGY ELLIPTA, Ozempic, CAPVAXIVE, REPATHA, JARDIANCE, EVENITY.
Industry payments across NY — which companies pay providers there.
